PHASE I DOSE ESCALATION STUDY OF PEMETREXED AND CARBOPLATIN IN CHEMOTHEARPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER.

被引:0
|
作者
Takeoka, Hiroaki [1 ]
Yamada, Kazuhiko [1 ]
Zaizen, Yoshiaki [1 ]
Shimamatsu, Fumie [1 ]
Azuma, Koichi [1 ]
Hoshino, Tomoaki [1 ]
机构
[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
关键词
non-small cell lung cancer; elderly; Carboplatin; pemetrexed;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.10-002
引用
收藏
页码:S859 / S859
页数:1
相关论文
共 50 条
  • [31] Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
    Shen, Xinglei
    DeNittis, Albert
    Werner-Wasik, Maria
    Axelrod, Rita
    Gilman, Paul
    Meyer, Thomas
    Treat, Joseph
    Curran, Walter J.
    Machtay, Mitchell
    RADIATION ONCOLOGY, 2011, 6
  • [32] A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer
    Tanai, Chiharu
    Yamamoto, Nobuyuki
    Ohe, Yuichiro
    Takahashi, Toshiaki
    Kunitoh, Hideo
    Murakami, Haruyasu
    Yamamoto, Noboru
    Nakamura, Yukiko
    Nokihara, Hiroshi
    Shukuya, Takehito
    Baldwin, John R.
    Koshiji, Minori
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) : 1068 - 1074
  • [33] Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
    Xinglei Shen
    Albert DeNittis
    Maria Werner-Wasik
    Rita Axelrod
    Paul Gilman
    Thomas Meyer
    Joseph Treat
    Walter J Curran
    Mitchell Machtay
    Radiation Oncology, 6
  • [34] First-line cisplatin plus pemetrexed therapy for selected patients with advanced nonsquamous non-small cell lung cancer.
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Imai, Hisao
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    Chow, L. Q. M.
    Blais, N.
    Jonker, D. J.
    Laurie, S. A.
    Diab, S. G.
    Canil, C.
    McWilliam, M.
    Thall, A.
    Ruiz-Garcia, A.
    Zhang, K.
    Tye, L.
    Chao, R. C.
    Camidge, D. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 709 - 722
  • [36] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    L. Q. M. Chow
    N. Blais
    D. J. Jonker
    S. A. Laurie
    S. G. Diab
    C. Canil
    M. McWilliam
    A. Thall
    A. Ruiz-Garcia
    K. Zhang
    L. Tye
    R. C. Chao
    D. R. Camidge
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 709 - 722
  • [37] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
  • [38] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [39] Phase II study of combination of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Mitsuoka, Shigeki
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Yoshimura, Naruo
    Hirata, Kazuto
    ANNALS OF ONCOLOGY, 2006, 17 : 227 - 227
  • [40] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519